Today: 9 April 2026
Boeing stock climbs as FAA chief says agency isn’t blocking 737 MAX 7, MAX 10 approvals
22 January 2026
1 min read

Boeing stock climbs as FAA chief says agency isn’t blocking 737 MAX 7, MAX 10 approvals

New York, January 22, 2026, 12:11 (EST) — Regular session

  • Boeing shares climbed midday after investors processed new FAA remarks on the long-delayed 737 MAX variants
  • A separate potential sale to Singapore approved by the U.S. lists Boeing as the principal contractor

Boeing shares climbed 1.4% to $253.48 in midday trading Thursday in New York. FAA Administrator Bryan Bedford told reporters the agency isn’t holding up certification for the 737 MAX 7 and MAX 10 jets, saying, “I don’t think FAA is the roadblock on 7 and the -10 certification.” He added that Boeing still needs to complete the necessary work. Boeing did not immediately reply to requests for comment. Reuters

This matters because certification is the green light from regulators allowing an aircraft to start passenger service. Without it, airlines can’t accept deliveries and Boeing can’t convert those orders into revenue, even if the sales are already on the books.

The MAX 7 and MAX 10 represent the extremes of Boeing’s 737 lineup, and both have faced delays. Investors see approval milestones as crucial tests of whether Boeing can finally steady deliveries after years of turmoil.

Aside from certification updates, Boeing faces the challenge of ramping up production. The MAX 10 will be built on a new assembly line in Everett, Washington, since its length makes it impractical to manufacture alongside other 737 models in Renton, where the company has produced 737s for decades.

Boeing’s defense division grabbed headlines again this week. The U.S. State Department gave the green light to a possible $2.3 billion deal with Singapore for maritime patrol and reconnaissance aircraft, lightweight torpedoes, and related gear. The Pentagon has tapped Boeing as the main contractor for the sale. Reuters

That type of approval doesn’t guarantee a signed contract, and timelines often slip. Yet defense projects can help steady results when commercial deliveries face delays from regulatory hurdles or factory issues.

The risk for bulls is that “not the roadblock” doesn’t mean “done.” Bedford was clear: Boeing still needs to complete the fixes and documentation, and the FAA has made it clear they won’t speed things up.

Headline risk remains a concern. A fresh quality issue or tougher regulatory action could once more throttle deliveries or halt production, and such developments usually hit Boeing’s stock sentiment fast.

Boeing is set to report its fourth-quarter earnings on Tuesday, January 27. CEO Kelly Ortberg and CFO Jay Malave will host a conference call with investors at 10:30 a.m. ET to discuss the results and answer questions. Boeing Investors

Traders will be eyeing that call for clues on delivery schedules and cash flow — and hoping for a clearer timeline on the MAX 7 and MAX 10 certification, which has left airlines and shareholders in suspense.

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Johnson & Johnson stock price rises today as investors weigh 2026 outlook — and talc lawsuit clock
Previous Story

Johnson & Johnson stock price rises today as investors weigh 2026 outlook — and talc lawsuit clock

MercadoLibre stock jumps nearly 4% — what traders are watching next
Next Story

MercadoLibre stock jumps nearly 4% — what traders are watching next

Go toTop